Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Montelukast Oral Granules 4 mg versus Singulair Oral Granules 4 mg in healthy Thai volunteers under fasting conditions
TCTR20200622003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by Bio-innova. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20200622003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200622003.